You have 9 free searches left this month | to do more

revlimid

Revlimid is a drug used to treat Multiple Myeloma, Lymphoma, Prostate Cancer, and other conditions. Revlimid is being actively studied in 3 studies and prior, has been studied in 12.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Duke University Medical CenterCaryn Steakley, R.N.
CelgeneAKH Linz, Innere Medizin 3, Zentrum fur Hamatologie und medizinische OnkologieDr. Sigrun Hallmeyer
Hackensack Meridian HealthASO KK Iizuka HospitalHareth Nahi
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Lymphoma
  • +3 more
  • obinutuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
U
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • CLL
  • La Jolla, California
    University of California, San Diego
2021-09-02
Sep 2, 2021
N
Active, not recruiting
  • Multiple Myeloma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
C
Unknown status
  • Lymphoma
  • Revlimid
  • Iizuka, Fukuoka, Japan
    ASO KK Iizuka Hospital
2019-09-11
Sep 11, 2019
S
Completed
  • Prostate Cancer
  • Revlimid
  • Baltimore, Maryland
    The Harry and Jeanette Weinberg Building
2019-04-11
Apr 11, 2019
R
Unknown status
  • Follicular Lymphoma
  • Revlimid
  • Shanghai, Shanghai, China
    Ruijin Hospital
2019-07-04
Jul 4, 2019
N
Terminated
  • Multiple Myeloma
  • Revlimid
  • +3 more
  • Los Angeles, California
  • +4 more
2018-06-26
Jun 26, 2018
D
Terminated
  • Multiple Myeloma
  • Durham, North Carolina
    Duke University Medical Center
2017-04-26
Apr 26, 2017
U
Completed
  • Waldenstrom Macroglobulinemia
  • Revlimid
  • Bayonne, France
  • +6 more
2017-06-06
Jun 6, 2017
N
Completed
  • Melanoma
  • Revlimid
  • Bethesda, Maryland
    National Cancer Institute (NCI)
2016-11-14
Nov 14, 2016
K
Completed
  • Multiple Myeloma
  • Revlimid
  • Stockholm, Sweden
  • +1 more
2016-03-24
Mar 24, 2016
U
Completed
  • Multiple Myeloma
  • Revlimid
  • Little Rock, Arkansas
    University of Arkansas for Medical Science-MIRT
2015-09-29
Sep 29, 2015
U
Completed
  • Acute Myeloid Leukemia
  • Revlimid
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Hospital
2015-06-17
Jun 17, 2015
M
Completed
  • Pancreatic Carcinoma.
  • Stockholm, Solna, Sweden
    Karolinska University Hospital
2014-11-26
Nov 26, 2014
A
Unknown status
  • Chronic Myelomonocytic Leukemia
  • Revlimid
  • Linz, Oberösterreich, Austria
  • +9 more
2015-03-06
Mar 6, 2015
O
Completed
  • Prostate Cancer
  • Revlimid
  • Niles, Illinois
  • +1 more
2014-02-28
Feb 28, 2014
H
Unknown status
  • Diffuse Large B-cell Lymphoma.
  • Revlimid
  • Hackensack, New Jersey
  • +1 more
2014-02-02
Feb 2, 2014
M
Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Revlimid
  • Houston, Texas
    UT MD Anderson Cancer Center
2013-08-05
Aug 5, 2013
H
Terminated
  • Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
  • Hackensack, New Jersey
    Hackensack University Medical Center
2012-11-07
Nov 7, 2012
U
Completed
  • Relapse
  • Refractory Multiple Myeloma
  • Revlimid
  • Wuerzburg, Bavaria, Germany
    Dept. of Internal Medicine II, University of Wuerzburg
2009-08-03
Aug 3, 2009